Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes.

Rawat V, Wang S, Sima J, Bar R, Liraz O, Gundimeda U, Parekh T, Chan J, Johansson JO, Tang C, Chui HC, Harrington MG, Michaelson DM, Yassine HN.

J Neurosci. 2019 Nov 27;39(48):9611-9622. doi: 10.1523/JNEUROSCI.1400-19.2019. Epub 2019 Oct 22.

PMID:
31641056
2.

Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease.

Haarhaus M, Ray KK, Nicholls SJ, Schwartz GG, Kulikowski E, Johansson JO, Sweeney M, Halliday C, Lebioda K, Wong N, Brandenburg V, Beddhu S, Tonelli M, Zoccali C, Kalantar-Zadeh K.

Atherosclerosis. 2019 Nov;290:59-65. doi: 10.1016/j.atherosclerosis.2019.09.002. Epub 2019 Sep 17.

3.

Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial.

Ray KK, Nicholls SJ, Ginsberg HD, Johansson JO, Kalantar-Zadeh K, Kulikowski E, Toth PP, Wong N, Cummings JL, Sweeney M, Schwartz GG.

Am Heart J. 2019 Nov;217:72-83. doi: 10.1016/j.ahj.2019.08.001. Epub 2019 Aug 9.

PMID:
31520897
4.

Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism.

Tsujikawa LM, Fu L, Das S, Halliday C, Rakai BD, Stotz SC, Sarsons CD, Gilham D, Daze E, Wasiak S, Studer D, Rinker KD, Sweeney M, Johansson JO, Wong NCW, Kulikowski E.

Clin Epigenetics. 2019 Jul 12;11(1):102. doi: 10.1186/s13148-019-0696-z.

5.

ABCA1 Agonist Mimetic Peptide CS-6253 Induces Microparticles Release From Different Cell Types by ABCA1-Efflux-Dependent Mechanism.

Hafiane A, Johansson JO, Genest J.

Can J Cardiol. 2019 Jun;35(6):770-781. doi: 10.1016/j.cjca.2019.02.018. Epub 2019 Feb 27.

PMID:
31151713
6.

Apabetalone downregulates factors and pathways associated with vascular calcification.

Gilham D, Tsujikawa LM, Sarsons CD, Halliday C, Wasiak S, Stotz SC, Jahagirdar R, Sweeney M, Johansson JO, Wong NCW, Kalantar-Zadeh K, Kulikowski E.

Atherosclerosis. 2019 Jan;280:75-84. doi: 10.1016/j.atherosclerosis.2018.11.002. Epub 2018 Nov 14.

7.

Novel ABCA1 peptide agonists with antidiabetic action.

Azhar S, Bittner S, Hu J, Shen WJ, Cortez Y, Hao X, Han L, Lagerstedt JO, Kraemer FB, Johansson JO.

Mol Cell Endocrinol. 2019 Jan 15;480:1-11. doi: 10.1016/j.mce.2018.09.011. Epub 2018 Oct 2.

PMID:
30290217
8.

A Novel Synonymous Variant in the AVP Gene Associated with Autosomal Dominant Familial Neurohypophyseal Diabetes Insipidus Causes Partial RNA Missplicing.

Kvistgaard H, Christensen JH, Johansson JO, Gregersen N, Siggaard Rittig C, Rittig S, Corydon TJ.

Neuroendocrinology. 2018;107(2):167-180. doi: 10.1159/000491579. Epub 2018 Jun 27.

PMID:
29949799
9.

Benefit of Apabetalone on Plasma Proteins in Renal Disease.

Wasiak S, Tsujikawa LM, Halliday C, Stotz SC, Gilham D, Jahagirdar R, Kalantar-Zadeh K, Robson R, Sweeney M, Johansson JO, Wong NC, Kulikowski E.

Kidney Int Rep. 2017 Dec 8;3(3):711-721. doi: 10.1016/j.ekir.2017.12.001. eCollection 2018 May.

10.

Method for automatic detection of defective ultrasound linear array transducers based on uniformity assessment of clinical images - A case study.

Lorentsson R, Hosseini N, Johansson JO, Rosenberg W, Stenborg B, Månsson LG, Båth M.

J Appl Clin Med Phys. 2018 Mar;19(2):265-274. doi: 10.1002/acm2.12248. Epub 2018 Jan 11.

11.

Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease.

Nicholls SJ, Ray KK, Johansson JO, Gordon A, Sweeney M, Halliday C, Kulikowski E, Wong N, Kim SW, Schwartz GG.

Am J Cardiovasc Drugs. 2018 Apr;18(2):109-115. doi: 10.1007/s40256-017-0250-3.

PMID:
29027131
12.

Low-lying, Rydberg states of polycyclic aromatic hydrocarbons (PAHs) and cyclic alkanes.

Bohl E, Mignolet B, Johansson JO, Remacle F, Campbell EEB.

Phys Chem Chem Phys. 2017 Sep 13;19(35):24090-24099. doi: 10.1039/c7cp03913a.

PMID:
28835958
13.

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.

Johansson P, Almqvist EG, Bjerke M, Wallin A, Johansson JO, Andreasson U, Blennow K, Zetterberg H, Svensson J.

J Alzheimers Dis. 2017;59(3):1017-1026. doi: 10.3233/JAD-170226.

PMID:
28697566
14.

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.

Johansson P, Almqvist EG, Wallin A, Johansson JO, Andreasson U, Blennow K, Zetterberg H, Svensson J.

PLoS One. 2017 May 2;12(5):e0176760. doi: 10.1371/journal.pone.0176760. eCollection 2017.

15.

Directly probing spin dynamics in a molecular magnet with femtosecond time-resolution.

Johansson JO, Kim JW, Allwright E, Rogers DM, Robertson N, Bigot JY.

Chem Sci. 2016 Dec 1;7(12):7061-7067. doi: 10.1039/c6sc01105e. Epub 2016 Aug 1.

16.

Comparison of the low-contrast detectability of two ultrasound systems using a grayscale phantom.

Lorentsson R, Hosseini N, Johansson JO, Rosenberg W, Stenborg B, Månsson LG, Båth M.

J Appl Clin Med Phys. 2016 Nov 8;17(6):366-378. doi: 10.1120/jacmp.v17i6.6246.

17.

Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins.

Boehm-Cagan A, Bar R, Harats D, Shaish A, Levkovitz H, Bielicki JK, Johansson JO, Michaelson DM.

PLoS One. 2016 Nov 8;11(11):e0166195. doi: 10.1371/journal.pone.0166195. eCollection 2016.

18.

ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies.

Boehm-Cagan A, Bar R, Liraz O, Bielicki JK, Johansson JO, Michaelson DM.

J Alzheimers Dis. 2016 Oct 4;54(3):1219-1233.

PMID:
27567858
19.

Super-atom molecular orbital excited states of fullerenes.

Johansson JO, Bohl E, Campbell EE.

Philos Trans A Math Phys Eng Sci. 2016 Sep 13;374(2076). pii: 20150322. doi: 10.1098/rsta.2015.0322. Review.

20.

Relative Photoionization Cross Sections of Super-Atom Molecular Orbitals (SAMOs) in C60.

Bohl E, Sokół KP, Mignolet B, Thompson JO, Johansson JO, Remacle F, Campbell EE.

J Phys Chem A. 2015 Nov 25;119(47):11504-8. doi: 10.1021/acs.jpca.5b10339. Epub 2015 Nov 16.

PMID:
26551039
21.

Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease.

Johansson P, Almqvist EG, Wallin A, Johansson JO, Andreasson U, Blennow K, Zetterberg H, Svensson J.

Neurosci Lett. 2015 Nov 16;609:58-62. doi: 10.1016/j.neulet.2015.10.006. Epub 2015 Oct 8.

PMID:
26453765
22.

Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease.

Åberg D, Johansson P, Isgaard J, Wallin A, Johansson JO, Andreasson U, Blennow K, Zetterberg H, Åberg ND, Svensson J.

J Alzheimers Dis. 2015;48(3):637-46. doi: 10.3233/JAD-150351.

PMID:
26402100
23.

Human activities and climate variability drive fast-paced change across the world's estuarine-coastal ecosystems.

Cloern JE, Abreu PC, Carstensen J, Chauvaud L, Elmgren R, Grall J, Greening H, Johansson JO, Kahru M, Sherwood ET, Xu J, Yin K.

Glob Chang Biol. 2016 Feb;22(2):513-29. doi: 10.1111/gcb.13059. Epub 2015 Nov 20. Review.

PMID:
26242490
24.

Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.

Hafiane A, Bielicki JK, Johansson JO, Genest J.

PLoS One. 2015 Jul 24;10(7):e0131997. doi: 10.1371/journal.pone.0131997. eCollection 2015.

25.

Apolipoprotein E derived HDL mimetic peptide ATI-5261 promotes nascent HDL formation and reverse cholesterol transport in vitro.

Hafiane A, Bielicki JK, Johansson JO, Genest J.

Biochim Biophys Acta. 2014 Oct;1842(10):1498-512. doi: 10.1016/j.bbalip.2014.07.018. Epub 2014 Aug 1.

PMID:
25091998
26.

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.

Johansson P, Almqvist EG, Johansson JO, Mattsson N, Andreasson U, Hansson O, Wallin A, Blennow K, Zetterberg H, Svensson J.

PLoS One. 2013 Nov 29;8(11):e81989. doi: 10.1371/journal.pone.0081989. eCollection 2013.

27.

Dynamics of thermal electron emission from highly excited C60.

Johansson JO, Henderson GG, Campbell EE.

J Phys Chem A. 2014 Sep 18;118(37):8067-73. doi: 10.1021/jp408147f. Epub 2013 Nov 14.

PMID:
24175586
28.

Hot electron production and diffuse excited states in C70, C82, and Sc3N@C80 characterized by angular-resolved photoelectron spectroscopy.

Johansson JO, Bohl E, Henderson GG, Mignolet B, Dennis TJ, Remacle F, Campbell EE.

J Chem Phys. 2013 Aug 28;139(8):084309. doi: 10.1063/1.4818987.

PMID:
24006999
29.

Probing rapidly-ionizing super-atom molecular orbitals in C60: a computational and femtosecond photoelectron spectroscopy study.

Mignolet B, Johansson JO, Campbell EE, Remacle F.

Chemphyschem. 2013 Oct 7;14(14):3332-40. doi: 10.1002/cphc.201300585. Epub 2013 Aug 8.

PMID:
23929667
30.

Probing excited electronic states and ionisation mechanisms of fullerenes.

Johansson JO, Campbell EE.

Chem Soc Rev. 2013 Jul 7;42(13):5661-71. doi: 10.1039/c3cs60047e.

31.

Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.

Johansson P, Åberg D, Johansson JO, Mattsson N, Hansson O, Ahrén B, Isgaard J, Åberg ND, Blennow K, Zetterberg H, Wallin A, Svensson J.

Psychoneuroendocrinology. 2013 Sep;38(9):1729-37. doi: 10.1016/j.psyneuen.2013.02.006. Epub 2013 Mar 6.

PMID:
23473966
32.

Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease.

Johansson P, Almqvist EG, Johansson JO, Mattsson N, Hansson O, Wallin A, Blennow K, Zetterberg H, Svensson J.

Psychoneuroendocrinology. 2013 Jul;38(7):1058-66. doi: 10.1016/j.psyneuen.2012.10.012. Epub 2012 Nov 14.

PMID:
23159010
33.

Angular-resolved photoelectron spectroscopy of superatom orbitals of fullerenes.

Johansson JO, Henderson GG, Remacle F, Campbell EE.

Phys Rev Lett. 2012 Apr 27;108(17):173401. Epub 2012 Apr 24.

PMID:
22680862
34.

Anisotropic hot electron emission from fullerenes.

Johansson JO, Fedor J, Goto M, Kjellberg M, Stenfalk J, Henderson GG, Campbell EE, Hansen K.

J Chem Phys. 2012 Apr 28;136(16):164301. doi: 10.1063/1.4704828.

PMID:
22559476
35.

Leukocyte telomere length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's disease: a pilot study.

Movérare-Skrtic S, Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO, Zetterberg H, Blennow K, Svensson J.

Exp Gerontol. 2012 Feb;47(2):179-82. doi: 10.1016/j.exger.2011.12.005. Epub 2011 Dec 22.

PMID:
22210159
36.

Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility.

Mattsson N, Tabatabaei S, Johansson P, Hansson O, Andreasson U, Månsson JE, Johansson JO, Olsson B, Wallin A, Svensson J, Blennow K, Zetterberg H.

Neuromolecular Med. 2011 Jun;13(2):151-9. doi: 10.1007/s12017-011-8147-9. Epub 2011 May 13.

PMID:
21567187
37.

Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women.

Johansson P, Johansson JO, Labrie F, Mattsson N, Hansson O, Blennow K, Zetterberg H, Wallin A, Ohlsson C, Svensson J.

Clin Endocrinol (Oxf). 2011 Sep;75(3):301-8. doi: 10.1111/j.1365-2265.2011.04082.x.

PMID:
21521348
38.

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases.

Rosén C, Mattsson N, Johansson PM, Andreasson U, Wallin A, Hansson O, Johansson JO, Lamont J, Svensson J, Blennow K, Zetterberg H.

Front Aging Neurosci. 2011 Jan 31;3:1. doi: 10.3389/fnagi.2011.00001. eCollection 2011.

39.

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.

Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO, Andreasson U, Zetterberg H, Blennow K, Svensson J.

J Alzheimers Dis. 2011;24(3):537-46. doi: 10.3233/JAD-2011-101878.

PMID:
21297262
40.

Converging pathways of chromogranin and amyloid metabolism in the brain.

Mattsson N, Johansson P, Hansson O, Wallin A, Johansson JO, Andreasson U, Andersen O, Haghighi S, Olsson M, Stridsberg M, Svensson J, Blennow K, Zetterberg H.

J Alzheimers Dis. 2010;20(4):1039-49. doi: 10.3233/JAD-2010-091651. Erratum in: J Alzheimers Dis. 2011;23(4):761.

PMID:
20413871
41.

Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.

Faerch M, Christensen JH, Rittig S, Johansson JO, Gregersen N, de Zegher F, Corydon TJ.

Am J Physiol Renal Physiol. 2009 Dec;297(6):F1518-25. doi: 10.1152/ajprenal.00331.2009. Epub 2009 Oct 7.

42.

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

Mersebach H, Johansson JO, Rasmussen AK, Bengtsson BA, Rosenberg K, Hasholt L, Sørensen SA, Sørensen SS, Feldt-Rasmussen U.

Genet Med. 2007 Dec;9(12):812-8.

PMID:
18091430
43.

Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study.

Holmberg B, Johansson JO, Poewe W, Wenning G, Quinn NP, Mathias C, Tolosa E, Cardozo A, Dizdar N, Rascol O, Slaoui T; Growth-Hormone MSA Study Group; European MSA Study Group.

Mov Disord. 2007 Jun 15;22(8):1138-44.

PMID:
17469198
44.

Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease.

Schäfer E, Baron K, Widmer U, Deegan P, Neumann HP, Sunder-Plassmann G, Johansson JO, Whybra C, Ries M, Pastores GM, Mehta A, Beck M, Gal A.

Hum Mutat. 2005 Apr;25(4):412.

PMID:
15776423
45.

Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.

Morris DG, Kola B, Borboli N, Kaltsas GA, Gueorguiev M, McNicol AM, Ferrier R, Jones TH, Baldeweg S, Powell M, Czirják S, Hanzély Z, Johansson JO, Korbonits M, Grossman AB.

J Clin Endocrinol Metab. 2003 Dec;88(12):6080-7.

PMID:
14671214
46.
47.

Enzyme replacement in Anderson-Fabry disease.

Bengtsson BA, Johansson JO, Hollak C, Linthorst G, FeldtRasmussen U.

Lancet. 2003 Jan 25;361(9354):352. No abstract available.

PMID:
12559898
48.

Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.

Svensson J, Fowelin J, Landin K, Bengtsson BA, Johansson JO.

J Clin Endocrinol Metab. 2002 May;87(5):2121-7.

PMID:
11994351
49.

Identification of the TRM2 gene encoding the tRNA(m5U54)methyltransferase of Saccharomyces cerevisiae.

Nordlund ME, Johansson JO, von Pawel-Rammingen U, Byström AS.

RNA. 2000 Jun;6(6):844-60.

50.

Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridaemic men.

Johansson JO, Egberg N, Asplund-Carlson A, Carlson LA.

J Cardiovasc Risk. 1997 Jun;4(3):165-71.

PMID:
9475670

Supplemental Content

Loading ...
Support Center